| |
| |
|
| Insider
Information: |
Blank Burkhard |
| Relationship: |
EVP Chief Medical Offi... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
386,432 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,565,539 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
386,432 |
|
|
| Total
Value |
$1,565,539 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
CMO and Head of R&D |
2021-03-03 |
18,527 |
2016-07-01 |
0 |
Premium* |
|
|
MannKind Corp |
MNKD |
EVP Chief Medical Offi... |
2024-02-04 |
367,905 |
2023-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNKD |
MannKind Corp |
EVP Chief Medical Officer |
• – – |
2024-02-04 |
4 |
A |
$3.27 |
$499,999 |
D/D |
152,905 |
367,905 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Chief Medical Officer |
• – – |
2023-12-31 |
4 |
A |
$3.09 |
$15,450 |
D/D |
5,000 |
215,000 |
0 |
- |
|
| MNKD |
MannKind Corp |
EVP Chief Medical Officer |
• – – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
210,000 |
210,000 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
CMO and Head of R&D |
• – – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,125 |
18,527 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
CMO and Head of R&D |
• – – |
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,015 |
44,410 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
CMO and Head of R&D |
• – – |
2019-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
9,045 |
41,395 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
32,350 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
30,250 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-08-01 |
4 |
AS |
$24.69 |
$154,322 |
D/D |
(6,250) |
28,150 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-08-01 |
4 |
OE |
$16.50 |
$103,125 |
D/D |
6,250 |
34,400 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-07-02 |
4 |
AS |
$29.26 |
$148,050 |
D/D |
(5,000) |
28,150 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-05-18 |
4 |
AS |
$23.66 |
$591,588 |
D/D |
(25,000) |
33,150 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-05-18 |
4 |
OE |
$16.50 |
$412,500 |
D/D |
25,000 |
58,150 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-12-01 |
4 |
AS |
$20.53 |
$226,893 |
D/D |
(11,050) |
33,150 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2017-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,200 |
44,200 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2016-12-01 |
4 |
AS |
$20.74 |
$207,442 |
D/D |
(10,000) |
40,000 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Medical Officer |
• – – |
2016-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
